Liza Lindenberg

2 months ago | jnm.snmjournals.org | Liza Lindenberg |Thomas A Hope |Frank Lin |Steven Rowe

RESULTSOf 32 patients screened, 30 were enrolled into the study and received 68Ga-PSMA-R2. Two patients without BCR or mPC were not enrolled. In phase 1, 6 patients with BCR were enrolled; in phase 2, 24 patients with BCR or mPC (n = 12 each) were enrolled (Supplemental Table 2). All participants completed the imaging assessment on day 1. Most participants were White (90%, 27/30) with a median age of 70.5 y (range, 53–86 y) (Table 1).

Nov 5, 2024 | ejnmmires.springeropen.com | Fahmida Haque |Jorge Carrasquillo |Evrim Turkbey |Esther Mena |Liza Lindenberg |Naris Nilubol | +6 more

In this study, three independent clinical trial populations were used to develop and validate the AI model. Detailed information about the DOTATATE PET/CT scans of all three cohorts is listed in Table 1. The first cohort consists of 38 adult patients undergoing Lu-177-DOTATATE treatment for inoperable, metastatic, and histologically proven Pheochromocytoma/Paraganglioma (NCT03206060), referred to as PPGL cohort for the remainder of the study.